Risk Minimisation Materials
Search by company, common medicine name, or title of Risk Minimisation Material
Jaydess
Bayer plc
Jemperli
GlaxoSmithKline UK
Jext
ALK-Abello Ltd
Jext® Childrens Video Demonstration
Jext® Expiry Alert
Jext® Video Demonstration
Jinarc
Otsuka Pharmaceuticals (UK) Ltd
JINARC UK aRMM - Patient Card
Patient card content description:
Additional Risk Minimisation Materials (aRMM) are essential for ensuring patient safety and reducing the risks associated with the use of medicines.
The Patient Card for JINARC® (tolvaptan), is to minimise the risks of: • Liver injury / abnormal liver function • Severe dehydration / excessive water loss • Use during pregnancy and breastfeeding, including the need for effective contraception in women of childbearing potential
Patient Card provides important safety information for patients receiving tolvaptan, including information on the risks of liver injury and dehydration, symptoms to be aware of, and actions to take.
Hard copies can be requested by emailing [email protected].
JINARC UK aRMM - Patient Educational Material
Additional Risk Minimisation Materials (aRMM) are essential for ensuring patient safety and reducing the risks associated with the use of medicines.
The Patient Educational Material for JINARC® (tolvaptan), is to minimise the risks of: • Liver injury / abnormal liver function • Severe dehydration / excessive water loss • Use during pregnancy and breastfeeding, including the need for effective contraception in women of childbearing potential
The educational materials are intended to support safe use of tolvaptan by informing patients, carers and healthcare professionals of the need for liver function monitoring, recognition and prompt management of signs and symptoms suggestive of liver injury, prevention and management of dehydration/excessive water loss, and avoidance of use during pregnancy and breastfeeding.
Patient Educational Material provides important information on treatment, liver injury and dehydration risks, fluid intake, pregnancy prevention, use of the Patient Card, and reporting of side effects.
Hard copies can be requested by emailing [email protected].
Jubbonti
Sandoz Limited
Junod.
Gedeon Richter (UK) Ltd
Junod 60 mg solution for injection in pre-filled syringe Patient Reminder Card
Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.
Jylamvo 2 mg/ml oral solution
Esteve Pharmaceuticals (formerly Intrapharm Laboratories)
Guide for Healthcare Professionals - Jylamvo (Methotrexate) 2 mg/ml oral solution
Guide for Healthcare Professionals - Jylamvo (Methotrexate) 2 mg/ml oral solution
Jyseleca
Alfasigma UK Limited (formerly Galapagos Biotech Limited)
You are trying to reach a document intended for healthcare professionals only.
Are you a healthcare professional?
You are trying to reach a document intended for healthcare professionals only.
Are you a healthcare professional?